{"entities":{"Q9849":{"pageid":14010,"ns":120,"title":"Item:Q9849","lastrevid":205770,"modified":"2020-05-21T15:46:13Z","type":"item","id":"Q9849","labels":{"en":{"language":"en","value":"De Jesus-Acosta A, et al. Invest. N. Drugs (2014) cited as Ref 586 in DOI: 10.1038/s41392-020-0110-5"}},"descriptions":{"en":{"language":"en","value":"Cited in: \"Targeting cancer stem cell pathways for cancer therapy\" in Signal Transduct Target Ther; 2020 ; 5 8"}},"aliases":[],"claims":{"P17":[{"mainsnak":{"snaktype":"value","property":"P17","datavalue":{"value":{"entity-type":"item","numeric-id":7916,"id":"Q7916"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9849$28532628-5C6B-4E0D-A3A5-0B5C0D83B860","rank":"normal"}],"P94":[{"mainsnak":{"snaktype":"value","property":"P94","datavalue":{"value":{"entity-type":"item","numeric-id":8449,"id":"Q8449"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9849$F6A63B6B-8073-43AE-9E2B-4ED71BBD1C7C","rank":"normal"}],"P149":[{"mainsnak":{"snaktype":"value","property":"P149","datavalue":{"value":"De Jesus-Acosta A","type":"string"},"datatype":"string"},"type":"statement","id":"Q9849$3124C467-543F-424E-9A37-266F5BC26F6D","rank":"normal"}],"P138":[{"mainsnak":{"snaktype":"value","property":"P138","datavalue":{"value":"10.1007/s10637-014-0083-8","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q9849$03F546C1-BFCA-442D-A51D-01EBD13CE765","rank":"normal"}],"P100":[{"mainsnak":{"snaktype":"value","property":"P100","datavalue":{"value":{"time":"+2014-01-01T00:00:00Z","timezone":0,"before":0,"after":0,"precision":9,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q9849$C74E5F23-7CB1-4BB1-A2D9-73F6C67020B3","rank":"normal"}],"P102":[{"mainsnak":{"snaktype":"value","property":"P102","datavalue":{"value":"Invest. N. Drugs","type":"string"},"datatype":"string"},"type":"statement","id":"Q9849$27334CD0-57FD-4AB7-B472-8AB7BD9FDC07","rank":"normal"}],"P103":[{"mainsnak":{"snaktype":"value","property":"P103","datavalue":{"value":"32","type":"string"},"datatype":"string"},"type":"statement","id":"Q9849$DEB79B10-D14B-4A18-9A3A-EEA16A53FDFC","rank":"normal"}],"P93":[{"mainsnak":{"snaktype":"value","property":"P93","datavalue":{"value":{"text":"A phase II study of the gamma secretase inhibitor RO4929097 in patients with previously treated metastatic pancreatic adenocarcinoma","language":"en"},"type":"monolingualtext"},"datatype":"monolingualtext"},"type":"statement","id":"Q9849$9832B21B-6523-4BF6-8DB4-A7D16BBA9A50","rank":"normal"}],"P105":[{"mainsnak":{"snaktype":"value","property":"P105","datavalue":{"value":"739-745","type":"string"},"datatype":"string"},"type":"statement","id":"Q9849$C52ED993-E2D5-4A8D-812F-0E6FAEE81AF8","rank":"normal"}]},"sitelinks":{"sliswiki":{"site":"sliswiki","title":"De Jesus-Acosta A, et al. Invest. N. Drugs (2014) cited as Ref 586 in DOI: 10.1038/s41392-020-0110-5","badges":[],"url":"https://wikibase.slis.ua.edu/wiki/De_Jesus-Acosta_A,_et_al._Invest._N._Drugs_(2014)_cited_as_Ref_586_in_DOI:_10.1038/s41392-020-0110-5"}}}}}